Works by Thompson, T. C.

Results: 24

AN OLD LINE ENGRAVING.

Published in:

Notes & Queries, 1883, v. 8, n. 193, p. 199-c

By:

THOMPSON, C. T.

Publication type:

Article

Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.

Published in:

British Journal of Cancer, 2013, v. 109, n. 12, p. 3105, doi. 10.1038/bjc.2013.669

By:

Tan, X;
Wang, Y;
Han, Y;
Chang, W;
Su, T;
Hou, J;
Xu, D;
Yu, Y;
Ma, W;
Thompson, T C;
Cao, G

Publication type:

Article

Experimental and analytical studies on the performance of hybrid isolation systems.

Published in:

Earthquake Engineering & Structural Dynamics, 2002, v. 31, n. 2, p. 421, doi. 10.1002/eqe.117

By:

Chang, Shih-Po;
Makris, Nicos;
Whittaker, Andrew S.;
Thompson, Andrew C. T.

Publication type:

Article

DNA damage response and prostate cancer: defects, regulation and therapeutic implications.

Published in:

Oncogene, 2015, v. 34, n. 22, p. 2815, doi. 10.1038/onc.2014.238

By:

Karanika, S;
Karantanos, T;
Li, L;
Corn, P G;
Thompson, T C

Publication type:

Article

DNA ploidy and clonal selection in ras + myc - Induced mouse prostate cancer.

Published in:

International Journal of Cancer, 1995, v. 60, n. 3, p. 395, doi. 10.1002/ijc.2910600321

By:

Greene, D. R.;
Taylor, S. R.;
Aihara, M.;
Yoshida, K.;
Egawa, S.;
Park, S. H.;
Timme, T. L.;
Yang, G.;
Scardino, P. T.;
Thompson, T. C.

Publication type:

Article

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.

Published in:

Oncogene, 2013, v. 32, n. 49, p. 5501, doi. 10.1038/onc.2013.206

By:

Karantanos, T;
Corn, P G;
Thompson, T C

Publication type:

Article

Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study.

Published in:

European Journal of Endocrinology, 2015, v. 172, n. 3, p. 243, doi. 10.1530/EJE-14-0719

By:

Behan, L. A.;
Sherlock, M.;
Moyles, P.;
Renshaw, O.;
Thompson, C. J. T.;
Orr, C.;
Holte, K.;
Salehmohamed, M. R.;
Glynn, N.;
Tormey, W.;
Thompson, C. J.

Publication type:

Article

The role of caveolin-1 in prostate cancer: clinical implications.

Published in:

Prostate Cancer & Prostatic Diseases, 2010, v. 13, n. 1, p. 6, doi. 10.1038/pcan.2009.29

By:

Thompson, T. C.;
Tahir, S. A.;
Li, L.;
Watanabe, M.;
Naruishi, K.;
Yang, G.;
Kadmon, D.;
Logothetis, C. J.;
Troncoso, P.;
Ren, C.;
Goltsov, A.;
Park, S.

Publication type:

Article

Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 3, p. 301, doi. 10.1038/pcan.2008.57

By:

Tabata, K.;
Watanabe, M.;
Naruishi, K.;
Edamura, K.;
Satoh, T.;
Yang, G.;
Fattah, E. Abdel;
Wang, J.;
Goltsov, A.;
Floryk, D.;
Soni, S. D.;
Kadmon, D.;
Thompson, T. C.

Publication type:

Article

The emerging role of the PI3-K-Akt pathway in prostate cancer progression.

Published in:

Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 2, p. 108, doi. 10.1038/sj.pcan.4500776

By:

Li, L.;
Ittmann, M. M.;
Ayala, G.;
Tsai, M.-J.;
Amato, R. J.;
Wheeler, T. M.;
Miles, B. J.;
Kadmon, D.;
Thompson, T. C.

Publication type:

Article

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.

Published in:

Prostate Cancer & Prostatic Diseases, 2002, v. 5, n. 4, p. 316, doi. 10.1038/sj.pcan.4500610

By:

Ebara, S;
Shimura, S;
Nasu, Y;
Kaku, H;
Kumon, H;
Yang, G;
Wang, J;
Timme, T L;
Aguilar-Cordova, E;
Thompson, T C

Publication type:

Article

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2001, v. 4, n. 1, p. 44, doi. 10.1038/sj.pcan.4500494

By:

Nasu, Y;
Bangma, C H;
Hull, G W;
Yang, G;
Wang, J;
Shimura, S;
McCurdy, M A;
Ebara, S;
Lee, H-M;
Timme, T L;
Thompson, T C

Publication type:

Article

Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.

Published in:

1998

By:

Stapleton, Alan M. F.;
Zbell, Paul;
Kattan, Michael W.;
Yang, Guang;
Wheeler, Thomas M.;
Scardino, Peter T.;
Thompson, Timothy C.;
Stapleton, A M;
Zbell, P;
Kattan, M W;
Yang, G;
Wheeler, T M;
Scardino, P T;
Thompson, T C

Publication type:

journal article

The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate.

Published in:

1995

By:

Aihara, Masahiro;
Scardino, Peter T.;
Truong, Luan D.;
Wheeler, Thomas M.;
Goad, Jeremy R.;
Yang, Guang;
Thompson, Timothy C.;
Aihara, M;
Scardino, P T;
Truong, L D;
Wheeler, T M;
Goad, J R;
Yang, G;
Thompson, T C

Publication type:

journal article

Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.

Published in:

Gene Therapy, 2011, v. 18, n. 10, p. 969, doi. 10.1038/gt.2011.51

By:

Tabata, K;
Kurosaka, S;
Watanabe, M;
Edamura, K;
Satoh, T;
Yang, G;
Abdelfattah, E;
Wang, J;
Goltsov, A;
Floryk, D;
Thompson, T C

Publication type:

Article

Gene-modified bone marrow cell therapy for prostate cancer.

Published in:

Gene Therapy, 2008, v. 15, n. 10, p. 787, doi. 10.1038/gt.2008.37

By:

Wang, H.;
Thompson, T. C.

Publication type:

Article

Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.

Published in:

Gene Therapy, 2007, v. 14, n. 3, p. 227, doi. 10.1038/sj.gt.3302788

By:

Fujita, T.;
Timme, T. L.;
Tabata, K.;
Naruishi, K.;
Kusaka, N.;
Watanabe, M.;
Abdelfattah, E.;
Zhu, J. X.;
Ren, C.;
Yang, G.;
Goltsov, A.;
Wang, H.;
Vlachaki, M. T.;
Teh, B. S.;
Butler, E. B.;
Thompson, T. C.

Publication type:

Article

Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.

Published in:

Gene Therapy, 1999, v. 6, n. 3, p. 338, doi. 10.1038/sj.gt.3300834

By:

Nasu, Y;
Bangma, C H;
Hull, G W;
Lee, H-M;
Hu, J;
Wang, J;
McCurdy, M A;
Shimura, S;
Yang, G;
Timme, T L;
Thompson, T C

Publication type:

Article

Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses.

Published in:

2001

By:

Griffith, Thomas S.;
Kawakita, Mutsushi;
Tian, Jun;
Ritchey, Julie;
Tartaglia, James;
Sehgal, Inder;
Thompson, Timothy C.;
Weicheng Zhao;
Ratliff, Timothy L.;
Griffith, T S;
Kawakita, M;
Tian, J;
Ritchey, J;
Tartaglia, J;
Sehgal, I;
Thompson, T C;
Zhao, W;
Ratliff, T L

Publication type:

journal article

Bicycle Access to Public Libraries: a Survey of Pennsylvania Public Libraries and Their Accessibility to Patrons Arriving Via Bicycle.

Published in:

Library Philosophy & Practice, 2006, v. 9, n. 1, p. 1

By:

Thompson, Samuel T. C.

Publication type:

Article

IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 10, p. 819, doi. 10.1038/sj.cgt.7701069

By:

Wang, H.;
Yang, G.;
Timme, T. L.;
Fujita, T.;
Naruishi, K.;
Frolov, A.;
Brenner, M. K.;
Kadmon, D.;
Thompson, T. C.

Publication type:

Article

IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.

Published in:

2007

By:

Wang, H.;
Yang, G.;
Timme, T. L.;
Fujita, T.;
Naruishi, K.;
Frolov, A.;
Brenner, M. K.;
Kadmon, D.;
Thompson, T. C.

Publication type:

Correction Notice

Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 7, p. 658, doi. 10.1038/sj.cgt.7700919

By:

Naruishi, K.;
Timme, T. L.;
Kusaka, N.;
Fujita, T.;
Yang, G.;
Goltsov, A.;
Satoh, T.;
Ji, X.;
Tian, W.;
Abdelfattah, E.;
Men, T.;
Watanabe, M.;
Tabata, K.;
Thompson, T. C.

Publication type:

Article

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 1, p. 91, doi. 10.1038/sj.cgt.7700872

By:

Saika, T.;
Kusaka, N.;
Mouraviev, V.;
Satoh, T.;
Kumon, H.;
Timme, T. L.;
Thompson, T. C.

Publication type:

Article